Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Abatacept in Rheumatoid Arthritis
NCT01333878Phase 3Completed
- Sponsor
- Orrin M Troum, M.D. and Medical Associates
- Start
- Mar 2011
- Primary completion
- Nov 2013
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of abatacept in rheumatoid arthritis (RA), sponsored by Orrin M Troum, M.D. and Medical Associates. Started Mar 2011; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01333878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01333878.